Browsing Tag
South San Francisco
3 posts
QNCX: What does the reverse merger hunt at Quince Therapeutics mean for shareholders after the NEAT trial collapse?
Quince Therapeutics (Nasdaq: QNCX) has no pipeline and a September Nasdaq deadline. Here's what the reverse merger hunt actually means for retail investors watching this stock.
April 8, 2026
The new engine of drug discovery? Inside Thermo Fisher Scientific’s cryo-EM hub in the Bay Area
Thermo Fisher Scientific opens a cryo-EM drug discovery center in South San Francisco to accelerate structural biology research. Discover why this matters for pharma.
March 5, 2026
Novo Nordisk and Septerna forge $2.2bn GPCR deal to develop oral therapies for obesity and diabetes
Novo Nordisk partners with Septerna in a $2.2B deal to develop oral GPCR therapies for obesity and diabetes. Explore the full stock sentiment and deal impact.
May 14, 2025